Physician profile
Ellen C Young
NPI 1205161957
$9,006.60
in general payments reported to CMS, 2019-2025
45 companies · $1,630 in 2025
The $1,630 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,969 · 2022: $2,294 · 2023: $1,494 · 2024: $1,620 · 2025: $1,630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,743.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,394.48 | 2021-2025 | |
| Lilly USA, LLC | $873.15 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $861.76 | 2021-2025 | Ozempic, Rybelsus, Tresiba |
| Astrazeneca Pharmaceuticals LP | $689.43 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $516.47 | 2021-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $506.00 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $458.21 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $404.55 | 2021-2025 | Rexulti, Abilify Asimtufii |
| Bayer Healthcare Pharmaceuticals INC. | $395.78 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $298.49 | 2021-2023 | Glassia |
| Biohaven Pharmaceuticals, INC. | $224.67 | 2021 | |
| Esperion Therapeutics, INC. | $207.15 | 2021-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $203.79 | 2021-2022 | |
| Abbott Laboratories | $187.30 | 2021-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $179.85 | 2021-2024 | Trelegy Ellipta, Shingrix |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.